OraSure Technologies received takeover bid from industry entrepreneur, sources say
In June, Zwanziger submitted an unsolicited all-cash proposal to buy the Bethlehem, Pennsylvania-headquartered company, known for its COVID-19 rapid antigen tests, the sources said.
Along with a prominent Wall Street investor and others - people the sources did not identify - Zwanziger proposed paying between $3.50 and $4.00 a share for OraSure. OraSure's stock was trading aT $3.18 on Monday morning, leaving it with a market capitalization of $238.6 million.
The company's board rejected the offer not long after it was sent, without any discussions between the parties, the three sources said.
A company representative did not immediately respond to a request for comment.
A representative for Zwanziger, a serial deal maker who cemented his reputation through at-home blood glucose testing, could not be reached for comment.
Zwanziger has built and sold a handful of diagnostic companies during his long career, and sold diagnostic test manufacturer Alere Abbott Laboratories in 2017 for around $5.3 billion.
The rebuffed offer for OraSure was his second effort to combine with the company, according to one of the sources. In 2022, only a few months after the company named Carrie Eglinton Manner as its chief executive officer, Zwanziger proposed a merger through a stock swap, but terms could not be reached, the source said.
OraSure appealed to Zwanziger because of its solid core technology and he thought he could turn around the company's fortunes quickly with a new team, the sources said.
The company's stock price has fallen 27 per cent in the last 12 months and is off 77 per cent over the last five years. Quarterly revenue has been dropping since early 2023 as COVID-19 era sales dried up.
OraSure has been attempting to diversify its business as a result, buying Sherlock Biosciences late last year for its molecular diagnostics platform.
Point of care diagnostic companies offer accurate results in real time to measure cholesterol, and detect flu and pregnancy, for example. But the industry still remains highly fragmented with companies such as Danaher, Siemens, Roche and Thermo Fisher Scientific capturing the biggest market share.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
an hour ago
- CNA
US AI startups see funding surge while more VC funds struggle to raise, data shows
U.S. startup funding surged 75.6 per cent in the first half of 2025, thanks to the continued AI boom, putting it on track for its second-best year ever, even as venture capital firms struggled to raise money, a report from PitchBook on Tuesday showed. Startup funding in the first six months of 2025 jumped to $162.8 billion, marking the strongest performance since the same period in 2021 — the historic peak for venture capital activity. That previous surge came during the era of the Zero Interest Rate Policy (ZIRP), when central banks slashed rates to stimulate economic activity during the COVID-19 pandemic, sending capital into higher-risk assets including venture capital. This year's boom has been driven largely by major AI investments and bold bets from big tech companies, a wave of activity set off by the debut of ChatGPT in late 2022. In the past three months alone, $69.9 billion was invested in U.S. startups. Standout deals included OpenAI's $40 billion round and Meta's $14.3 billion purchase of a stake in Scale AI. Other AI deals exceeding $1 billion in the second quarter included significant investments in Safe Superintelligence, Thinking Machine Labs, Anduril, and Grammarly. These deals underscore sustained investor conviction in the AI sector, which accounted for 64.1 per cent of the total deal value and 35.6 per cent of the deal count in the first half of the year. "I think it's downstream of the fact that OpenAI and Anthropic continue to grow at unbelievable rates," said Davis Treybig, partner at VC firm Innovation Endeavors. "If there's even a chance you could see that sort of progress in other domains, whether it's robotics, protein folding models, world models or video models, then there's a lot of people who are going to want to invest a lot of money." HARDER FOR VC FUNDS In contrast, U.S. venture capital fundraising continued to face headwinds, with just $26.6 billion raised across 238 funds in the first half of the year. This subdued environment represents a 33.7 per cent year-over-year decline in capital raised, extending the downward trend from 2024. It is also taking fund managers longer to close new vehicles, with the median time stretching to 15.3 months by the second quarter of 2025 - the longest in over a decade, data shows. The disconnection from the startup market reflects concerns from limited partners on the asset class due to recent underperformance and liquidity constraints. A rebound in exit activity, including IPOs and M&A, has brought a sense of optimism for the remainder of the year. Exit activity in the second quarter was up 40 per cent from last year, as a loosening antitrust environment and a thawing IPO market boost confidence. Sectors aligned with President Donald Trump's priorities such as AI, national security, defense technology, fintech and crypto dominated IPO interest in the second quarter, the report noted.
CNA
2 hours ago
- CNA
Nvidia to resume H20 GPU chip sales to Beijing, launches China-compliant model
Nvidia said on Monday (Jul 15) that it will resume sales of its H20 graphics processing unit (GPU) chips to China and has introduced a new model tailored to meet regulatory requirements in the Chinese market. According to a company blog post, Nvidia is filing applications to resume H20 sales with the United States government and expects to get the licenses soon. Deliveries are expected to begin shortly thereafter. The company announced a new RTX Pro GPU designed specifically for China. Nvidia described the model as "fully compliant" and suitable for digital twin AI applications in sectors such as smart factories and logistics. The chipmaker's CEO Jensen Huang met with US President Donald Trump and policymakers in Washington and later with officials in Beijing, as part of efforts to promote AI cooperation and highlight Nvidia's support for open-source research and global AI development, the company said. In May, Reuters reported that the company was planning to release a downgraded version of its H20 artificial intelligence chip for China following US export restrictions on the original model.
CNA
4 hours ago
- CNA
Despite tariffs, it's still America first for Asia's legacy automakers
SEOUL: Toyota and Hyundai Motor may have a beef with US protectionism, but they have one thing in common with President Donald Trump: when it comes to global car markets, it's America first for Asia's legacy automakers. Trump's tariffs on imported automobiles have upended the outlook for the global industry, yet the US remains by far the most important market for Japan's Toyota, South Korea's Hyundai and Asian rivals, including Honda and Nissan. North America accounts for at least 40 per cent of the revenue at both Toyota and Hyundai, filings show. The market's importance is unlikely to change any time soon, industry insiders and analysts said, especially with China, now the world's biggest auto market, dominated by homegrown electric vehicle makers such as BYD. Those Asian legacy carmakers with more robust margins and a strong hybrid lineup - such as Toyota, Hyundai, Kia Corp and to a lesser extent Honda - are more likely to weather the US tariffs storm, and potentially take market share from weaker players like Nissan, analysts said. "The environment that we're in now is becoming increasingly harsh and uncertain, starting with US tariffs," Mazda executive officer Noriyuki Takimura told reporters at an event in Tokyo last week. Mazda aims to strike a balance between "defensive" measures like cost-cuts and "offensive" ones like strengthening its product lineup, he said. Two Hyundai insiders and two Japanese auto executives separately told Reuters they had no intention of downsizing their US businesses in response to tariffs, even as they acknowledged the difficulties ahead. All four spoke on condition of anonymity. The US is Toyota's biggest market in terms of vehicles. It sold 2.3 million vehicles there in 2024, including its Lexus brand, accounting for more than a fifth of its global total. As a source of revenue, North America was second only to Japan in the last financial year. Hyundai's North American revenue was the highest in almost a decade last year. Kim Chang-ho, an analyst at Korea Investment & Securities, estimated it generates around 60 per cent of its profits from the US, thanks to higher vehicle prices. Mocked in the US in the 1980s for its perceived shoddy quality, Hyundai doubled down there around a decade ago, especially after tensions between Beijing and Seoul and the rise of domestic electric vehicle (EV) makers saw it start to lose ground in China. "After years of putting in effort, our brand is finally gaining recognition in the US," one of the Hyundai insiders said. "So we will not take our hands off the US" "GAME OF CHICKEN" The US has seen a surge in demand for hybrids as consumers have become more concerned about the battery range, price and charging hassles of EVs. Fuel-efficient models such as hybrids will be a key driver to gaining market share, said Morningstar analyst Vincent Sun. Toyota, Hyundai and Kia have particularly strong hybrid offerings. So far, most legacy Asian automakers have avoided raising prices in the US, and stronger players are likely to continue to hold off doing so, despite lower profitability, analysts said. Instead, the focus will likely be on taking market share from lower-margin rivals like Nissan and Stellantis, analysts said. 'It will shape up like a game of chicken," said Kim Sung-rae, an analyst at Hanwha Investment & Securities. "Those who will hold up well will emerge as winners.' Over time, tariffs could be a catalyst to help drive consolidation in the industry, or at least deepen existing tie-ups. Investors wonder if tariffs could push Nissan to revive merger talks with Honda that fell apart this year. Mazda, which is 5.1 per cent owned by Toyota, and Subaru, which is 21 per cent owned by Toyota, could become more reliant on the bigger company. MORE INVESTMENT? While Hyundai and Kia have three US factories, they still import about two-thirds of the vehicles sold there. Toyota manufactured 1.3 million vehicles in the US last year, equal to 54 per cent of the vehicles it sold there. Japanese automakers have invested more than US$66 billion in US manufacturing since the 1980s, building some two dozen plants, according to the JAMA auto lobby group. At a White House event attended by Trump in March, Hyundai announced a US$21 billion investment plan, including a new steel factory, and a plan to boost US production capacity to 1.2 million vehicles a year. The tariffs are likely to encourage Japanese and South Korean automakers to invest more into expanding production capacity and localising supply chains to protect their positions, said Justinas Liuima of research firm Euromonitor International. They will also continue to benefit from one aspect of US protectionism: higher tariffs on Chinese EVs, which means they don't face the same Chinese competition in the US that they do in emerging Asian markets, Liuima said. China ships very few cars to the US, which imposed a 100 per cent tariff on imported Chinese EVs under the previous administration of President Joe Biden. One of the Japanese executives said it was not a matter of simply boosting US production, as high costs, especially of labour, would also weigh on profitability. "It is really a game-changer," Julie Boote, analyst at Pelham Smithers Associates in London, said about the potential longer-term tariff impact. Some automakers have held off giving guidance that takes into account tariffs for the full year, meaning investors may be in store for a rude awakening as companies adjust forecasts as they report quarterly earnings, she said.
